
### [MONDO:0019144](http://purl.obolibrary.org/obo/MONDO_0019144)
**Label:** hereditary thrombophilia due to congenital protein S deficiency

**Subclasses:** [MONDO:0013791](http://purl.obolibrary.org/obo/MONDO_0013791) (thrombophilia due to protein S deficiency, autosomal recessive), [MONDO:0012868](http://purl.obolibrary.org/obo/MONDO_0012868) (protein S acquired deficiency), 

**Corr. equiv. classes:** [OMIM:614514](http://purl.obolibrary.org/obo/OMIM_614514), [OMIM:612336](http://purl.obolibrary.org/obo/OMIM_612336), [Orphanet:26349](http://www.orpha.net/ORDO/Orphanet_26349), 

**Class expressions from DL-Learner:**

- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0004855](http://purl.obolibrary.org/obo/HP_0004855) (Reduced protein S activity) 83.33%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) 83.33%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0004855](http://purl.obolibrary.org/obo/HP_0004855) (Reduced protein S activity) and [HP:0100724](http://purl.obolibrary.org/obo/HP_0100724) (Hypercoagulability) 83.33%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0004855](http://purl.obolibrary.org/obo/HP_0004855) (Reduced protein S activity) and [HP:0030875](http://purl.obolibrary.org/obo/HP_0030875) (Abnormality of pulmonary circulation) 83.33%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0004855](http://purl.obolibrary.org/obo/HP_0004855) (Reduced protein S activity) and [HP:0030163](http://purl.obolibrary.org/obo/HP_0030163) (Abnormal vascular physiology) 83.33%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0004855](http://purl.obolibrary.org/obo/HP_0004855) (Reduced protein S activity) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 83.33%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0004855](http://purl.obolibrary.org/obo/HP_0004855) (Reduced protein S activity) and [HP:0005305](http://purl.obolibrary.org/obo/HP_0005305) (Cerebral venous thrombosis) 83.33%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) and [HP:0100724](http://purl.obolibrary.org/obo/HP_0100724) (Hypercoagulability) 83.33%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) and [HP:0030875](http://purl.obolibrary.org/obo/HP_0030875) (Abnormality of pulmonary circulation) 83.33%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) and [HP:0030780](http://purl.obolibrary.org/obo/HP_0030780) (Abnormality of the protein C anticoagulant pathway) 83.33%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) and [HP:0005305](http://purl.obolibrary.org/obo/HP_0005305) (Cerebral venous thrombosis) 83.33%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) and [HP:0004855](http://purl.obolibrary.org/obo/HP_0004855) (Reduced protein S activity) 83.33%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0003256](http://purl.obolibrary.org/obo/HP_0003256) (Abnormality of the coagulation cascade) and [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) 83.33%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0002795](http://purl.obolibrary.org/obo/HP_0002795) (Functional respiratory abnormality) and [HP:0004855](http://purl.obolibrary.org/obo/HP_0004855) (Reduced protein S activity) 83.33%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0002795](http://purl.obolibrary.org/obo/HP_0002795) (Functional respiratory abnormality) and [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) 83.33%


